COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03012620
Brief Title: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (AcSé)

First Submitted : January 2, 2017
First Submitted that Met QC Criteria : January 4, 2017
First Posted : January 6, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : December 11, 2020
Last Update Posted : December 16, 2020